Sana Biotechnology, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 20, 2025 Deadline to file Lead Plaintiff Motion.

Core Viewpoint - A class action has been initiated against Sana Biotechnology, Inc. for allegedly misleading investors regarding its financial stability and product development during the specified Class Period from March 17, 2023, to November 4, 2024 [1][3]. Group 1: Class Action Details - Investors who purchased securities during the Class Period can file a lead plaintiff motion by May 20, 2025 [1]. - The Portnoy Law Firm is offering complimentary case evaluations to affected investors [2]. Group 2: Allegations Against the Company - The complaint claims that Sana was at significant risk of lacking sufficient capital to sustain operations and product development [3]. - It is alleged that the Company's product programs, including SC291 in oncology, SC379, and SG299, were less promising than represented [3]. - The complaint suggests that Sana may reduce funding for or discontinue certain product candidates and significantly cut its workforce to conserve cash [3]. - As a result, the public statements made by the Company were materially false and misleading throughout the Class Period [3].